Tamsulosin Hydrochloride NDC 62135-775

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-775Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0775Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-775-30	62135077530	30 CAPSULE in 1 BOTTLE (62135-775-30)Marketed from Nov 1, 2023
62135-775-90	62135077590	90 CAPSULE in 1 BOTTLE (62135-775-90)Marketed from Sep 8, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tamsulosin Hydrochloride
Generic name (nonproprietary): tamsulosin hydrochloride
Active ingredients: Tamsulosin hydrochloride — .4 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207405
Marketing start: Aug 11, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 62135-775_45adcea0-c5c1-9431-e063-6294a90a0471SPL ID 45adcea0-c5c1-9431-e063-6294a90a0471SPL set ID 14db58df-7584-410b-8cf4-4b928dada859RxCUI 863669UNII 11SV1951MRUPC 0362135775308, 0362135775902
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135077530 followed by a unit qualifier and the quantity

Package 62135-0775-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 11, 2025.

Indications (excerpt from the label)

Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [ see Clinical Studies (14) ]. Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension. Tamsulosin hydrochloride capsules is an alpha 1 adrenoceptor antagonist indicated for treatment of the signs and symptoms of benign prostatic hyperplasia ( 1 ) Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207405

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207405
Product	Strength	Form · route	Labeler	Product NDC
Tamsulosin Hydrochloride	Tamsulosin hydrochloride .4 mg/1	CapsuleOral	Ascend Laboratories, LLC	67877-450
Tamsulosin Hydrochloride	Tamsulosin hydrochloride .4 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-1538
Tamsulosin Hydrochloride	Tamsulosin hydrochloride .4 mg/1	CapsuleOral	AvPAK	50268-740
Tamsulosin Hydrochloride	Tamsulosin hydrochloride .4 mg/1	CapsuleOral	A-S Medication Solutions	50090-3646
Tamsulosin Hydrochloride	Tamsulosin hydrochloride .4 mg/1	CapsuleOral	A-S Medication Solutions	50090-4906
Tamsulosin Hydrochloride	Tamsulosin hydrochloride .4 mg/1	CapsuleOral	Proficient Rx LP	71205-217
Tamsulosin Hydrochloride	Tamsulosin hydrochloride .4 mg/1	CapsuleOral	Golden State Medical Supply, Inc.	51407-879